《外圍股市》美股期貨全面續升不足0.5% 道指期貨升102點跑輸
美國連日公布經濟數據表現參差,投資者料聯儲局短期內不會「收水」,加上輝瑞與BioNTech合作研發新冠疫苗正式獲美國當局批准全面使用,紓緩對美國近期確診病例激增憂慮。亞太區股市今天普遍跟隨美股造好,滬指、昨天逆吐菲股、大馬及南韓股市升1.1%-1.6%;日經續升0.9%曾越27,800;港股由逾八個月低位連彈第二天,今天在阿里健康(00241.HK)、已九連跌屢尋底阿里巴巴(09988.HK)、海底撈(06862.HK)、碧桂園服務(06098.HK)、重磅股騰訊(00700.HK)、中績多賺1.5倍的藥明生物(02269.HK)、受益於澳門放寬入境檢測陰性期限的濠賭股銀娛(00027.HK)/金沙(01928.HK)及美團(03690.HK)急漲5.3%-12%帶動,午後升幅曾擴至512點或2%,高見25,622,現報25,571,續升461點或1.8%。不過,印尼及已兩連挫的越南逆跌0.7%及0.5%。
美股繼昨晚全面續升0.6%-1.55%後,期貨全面續升不足0.5%,道指期貨續跑輸報35,383,升102點或不足0.3%;已三連漲兼昨晚再破頂的納指一百期貨及標普五百期貨報15,368及4,489,續升0.4%及0.3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.